Sociedad Americana de Hirudoterapia

Microsurgical replantation of an ear with no venous repair

Case report published in Scand J Plast Reconstr Surg Hand Surg (2010)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportEnsayos clínicosHussey AJ, Kelly JI · Scandinavian journal of plastic and reconstructive surgery and hand surgery, 2010

Abstract

Replantation of an avulsed ear was completely successful with only arterial repair (to the superficial temporal artery) and the use of medicinal leeches.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article
Indexed MeSH termsAdultAmputation, TraumaticAnastomosis, SurgicalEar, ExternalHumansMaleMicrosurgeryReplantation

Resumen

Adult male underwent complete ear replantation with arterial repair only and medicinal leech therapy, achieving full auricular survival.

Por qué esto importa para la hirudoterapia

This case report describes the successful replantation of an avulsed ear achieved with only arterial repair (to the superficial temporal artery) and the use of medicinal leeches; no venous repair was performed. The abstract states leeches were 'used' without specifying the indication. This is relevant to ASH's domain as a documented instance of medicinal leech use in appendage replantation. The key caveat is that this is a single case report with no details on leech protocol, species, number, duration, or complications, and no comparative or outcome data beyond 'complete success.'

Citación

Microsurgical replantation of an ear with no venous repair.

Hussey AJ, Kelly JI · Scandinavian journal of plastic and reconstructive surgery and hand surgery, 2010

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.